> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-36/
- Published: 2021-04-04T12:00:00.000Z
- Updated: 2026-09-14T16:53:31.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148243

**Guidance on Combination Product Feedback**  
*Federal Register* notice: FDA makes available a final guidance entitled Requesting FDA Feedback on Combination Products.To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-12-04/pdf/2020-26700.pdf?ref=fdaweb.com). 4/02/2021  
  
**Protective Barrier Enclosures, Infusion Pump EUAs Revoked**  
*Federal Register* notice: FDA is announcing the revocations of Emergency Use Authorizations (EUAs) issued to manufacturers of certain protective barrier enclosures and to manufacturers of certain infusion pumps and accessories. FDA revoked the protective barrier enclosures EUA on 8/20 after becoming aware of new preliminary evidence from simulated intubation procedure models of potential adverse events that could occur or complications with protective barrier enclosures without negative pressure recently reported in the literature. The infusion pump EUA was revoked 9/21 based on information and experience since issuance of the umbrella EUA, Instead of an umbrella EUA, FDA may issue individual authorizations for infusion pumps and infusion pump accessories that meet the requisite EUA statutory criteria. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-12-04/pdf/2020-26697.pdf?ref=fdaweb.com). 4/02/2021  
  
**Notice on Complex Generic Meetings Guidance Corrected**  
*Federal Register* notice: FDA has corrected an 11/25/2021 notice on a guidance entitled *Formal Meetings Between the Food and Drug Administration and Abbreviated New Drug Application Applicants of Complex Products Under Generic Drug User Fee Amendments*. The notice was published with incorrect information in the Paperwork Reduction Act of 1995 section and this notice corrects the error. To view the notice, click [here](https://public-inspection.federalregister.gov/2020-26691.pdf?ref=fdaweb.com). 4/01/2021  

**FDA Renews Pharmacy Compounding Advisory Panel**  
*Federal Register* notice: FDA has announced the renewal of its Pharmacy Compounding Advisory Committee for an additional two years beyond the charter expiration date. The new charter will be in effect until 4/25/2022\. To view the notice, click [here](https://public-inspection.federalregister.gov/2020-26696.pdf?ref=fdaweb.com). 3/31/2021